CLINICAL CHEMISTRY TOTAL BILIRUBIN 04V5121 07P96-23

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2020-01-08 for CLINICAL CHEMISTRY TOTAL BILIRUBIN 04V5121 07P96-23 manufactured by Abbott Gmbh.

MAUDE Entry Details

Report Number3002809144-2020-00027
MDR Report Key9566071
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2020-01-08
Date of Report2020-03-05
Date of Event2019-12-16
Date Mfgr Received2020-02-13
Date Added to Maude2020-01-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactCHRISTIAN LEE
Manufacturer Street100 ABBOTT PARK ROAD DEPT 09B9, BLDG CP01-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224668-294
Manufacturer G1ABBOTT GMBH
Manufacturer StreetMAX-PLANCK-RING 2
Manufacturer CityWIESBADEN 65205
Manufacturer CountryGM
Manufacturer Postal Code65205
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCLINICAL CHEMISTRY TOTAL BILIRUBIN
Generic NameTOTAL BILIRUBIN
Product CodeCIG
Date Received2020-01-08
Model Number04V5121
Catalog Number07P96-23
Lot Number54539UQ02
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT GMBH
Manufacturer AddressMAX-PLANCK-RING 2 WIESBADEN 65205 GM 65205


Patients

Patient NumberTreatmentOutcomeDate
10 2020-01-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.